Clinical Trial Update: To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating the safety and efficacy of intramuscular and intravenous autologous adipose-derived mesenchymal stromal cells for treating cr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Autologous adipose-derived mesenchymal stromal cells (ADMSCs) (adipose-derived mesenchymal stromal cells)

Snippet

Sponsor: Kasiak Research Pvt. Ltd. | Conditions: Critical Limb Ischemia | Phase 1, Phase 2 | Status: UNKNOWN